Trimetazidine – Cardiology MCQ
Trimetazidine is an antianginal agent which acts by inhibition of:
A. Beta oxidation of fatty acids
B. Anaerobic metabolism of glucose
C. Calcium channels
D. Beta adrenergic receptors
Please check the YouTube video above for discussion
Related Posts
-
Epicardial ablation for VT – Cardiology MCQ
No Comments | Sep 12, 2014 -
Withholding of elective surgery after DES – Cardiology MCQ
No Comments | Jan 8, 2014 -
HCM by ESC 2014 guidelines – Cardiology MCQ
No Comments | May 18, 2015 -
Endomyocardial fibrosis – Cardiology MCQ
No Comments | Feb 3, 2011
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal